LFWD vs. NSPR, GUTS, ICCM, CTSO, VANI, APT, APYX, INO, SPAI, and OM
Should you be buying ReWalk Robotics stock or one of its competitors? The main competitors of ReWalk Robotics include InspireMD (NSPR), Fractyl Health (GUTS), IceCure Medical (ICCM), Cytosorbents (CTSO), Vivani Medical (VANI), Alpha Pro Tech (APT), Apyx Medical (APYX), Inovio Pharmaceuticals (INO), Safe Pro Group Inc. Common Stock (SPAI), and Outset Medical (OM). These companies are all part of the "medical equipment" industry.
ReWalk Robotics vs.
InspireMD (NYSE:NSPR) and ReWalk Robotics (NASDAQ:LFWD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability.
ReWalk Robotics received 5 more outperform votes than InspireMD when rated by MarketBeat users. Likewise, 100.00% of users gave ReWalk Robotics an outperform vote while only 4.44% of users gave InspireMD an outperform vote.
InspireMD currently has a consensus target price of $4.75, indicating a potential upside of 48.90%. ReWalk Robotics has a consensus target price of $9.17, indicating a potential upside of 419.36%. Given ReWalk Robotics' higher probable upside, analysts clearly believe ReWalk Robotics is more favorable than InspireMD.
InspireMD has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, ReWalk Robotics has a beta of 2.05, meaning that its share price is 105% more volatile than the S&P 500.
44.8% of InspireMD shares are owned by institutional investors. Comparatively, 26.8% of ReWalk Robotics shares are owned by institutional investors. 29.7% of InspireMD shares are owned by company insiders. Comparatively, 2.5% of ReWalk Robotics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
InspireMD has higher earnings, but lower revenue than ReWalk Robotics. InspireMD is trading at a lower price-to-earnings ratio than ReWalk Robotics, indicating that it is currently the more affordable of the two stocks.
ReWalk Robotics has a net margin of -77.21% compared to InspireMD's net margin of -413.96%. ReWalk Robotics' return on equity of -43.02% beat InspireMD's return on equity.
In the previous week, ReWalk Robotics had 5 more articles in the media than InspireMD. MarketBeat recorded 7 mentions for ReWalk Robotics and 2 mentions for InspireMD. InspireMD's average media sentiment score of 0.20 beat ReWalk Robotics' score of -0.16 indicating that InspireMD is being referred to more favorably in the media.
Summary
ReWalk Robotics beats InspireMD on 10 of the 16 factors compared between the two stocks.
Get ReWalk Robotics News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFWD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ReWalk Robotics Competitors List
Related Companies and Tools
This page (NASDAQ:LFWD) was last updated on 2/22/2025 by MarketBeat.com Staff
